Abstract
The treatment of chronic kidney disease requires a comprehensive approach that encompasses early diagnosis, innovative therapies, and prevention strategies. Early diagnosis plays a crucial role in the immediate identification of chronic kidney disease, allowing for rapid and effective interventions to prevent serious complications. This is especially important due to the silent progression of the disease, which can lead to irreversible kidney damage before symptoms become evident. Additionally, prompt diagnosis enables the implementation of specific therapies targeting the underlying cause of kidney failure, contributing to better prognoses and quality of life for patients.
Innovative therapies are continuously being developed for the treatment of chronic kidney disease. Advances in medications, dialysis techniques, and kidney transplantation are expanding the arsenal of treatments available to healthcare professionals. This includes the development of more effective and safer medications, as well as the application of minimally invasive techniques for treating complications associated with kidney disease. Furthermore, research into innovative therapies seeks more personalized and targeted approaches, taking into account the individual characteristics of each patient and the stage of the disease.
In parallel with therapies, prevention strategies play a fundamental role in reducing the incidence and progression of chronic kidney disease. This includes measures such as strict control of underlying conditions like hypertension and diabetes, which are significant risk factors for chronic kidney disease, and the implementation of rigorous patient monitoring and education protocols. Additionally, promoting healthy lifestyle habits, such as a balanced diet and physical exercise, and active surveillance to detect and treat potential kidney function impairments early are essential components of prevention strategies.
In summary, the effective treatment of chronic kidney disease requires a multifaceted approach involving early diagnosis, innovative therapies, and prevention strategies. These integrated approaches have the potential to significantly reduce the morbidity and mortality associated with chronic kidney disease, ensuring a better quality of life and future prospects for patients.
References
ARTEAGA-MULLER, Giovanna Yazmín et al. Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation. Nutrients, v. 16, n. 1109, 2024.
CHEN, Teresa K. et al. Advances in the management of chronic kidney disease. BMJ, v. 383, n. 074216, 2023.
DI COSTANZO, Assunta et al. SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases. International Journal of Molecular Sciences, v. 24, n. 8732, 2023.
EVANS, Marc et al. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives. Advances in Therapy, v. 39, p. 33-43, 2022.
GAN, Ting et al. Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives. 2020, v. 16, n. 14, p. 2518-2526, 2020.
KALANTAR-ZADEH, Kamyar et al. Chronic kidney disease. The Lancet, v. 398, August 28, 2021.
LUO, Yuxin et al. Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrology, v. 25, n. 63, 2024.
MENDE, Christian W. Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape. Advances in Therapy, v. 39, p. 148-164, 2022.
NAKAYAMA, Masaaki et al. Application of Electrolyzed Hydrogen Water for Management of Chronic Kidney Disease and Dialysis Treatment—Perspective View. Antioxidants, v. 13, n. 90, 2024.
SCHAEFER, Franz et al. Investigating the use of fnerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies. Trials, v. 25, n. 203, 2024.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Leandro de Oliveira Veloso , Maria Eduarda Gomes Dal Molin, Carla Marinato Mosca Moschini, Thalita Bellotti Bogéa , Victoria Carolina Barcelos Fonseca